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Summary
Perturbed neuronal proteostasis is a salient feature shared by
both aging and protein misfolding disorders. The proteostasis
network controls the health of the proteome by integrating
pathways involved in protein synthesis, folding, trafficking,
secretion, and their degradation. A reduction in the buffering
capacity of the proteostasis network during aging may increase
the risk to undergo neurodegeneration by enhancing the accu-
mulation of misfolded proteins. As almost one-third of the
proteome is synthetized at the endoplasmic reticulum (ER),
maintenance of its proper function is fundamental to sustain
neuronal function. In fact, ER stress is a common feature of most
neurodegenerative diseases. The unfolded protein response
(UPR) operates as central player to maintain ER homeostasis or
the induction of cell death of chronically damaged cells. Here, we
discuss recent evidence placing ER stress as a driver of brain
aging, and the emerging impact of neuronal UPR in controlling
global proteostasis at the whole organismal level. Finally, we
discuss possible therapeutic interventions to improve proteosta-
sis and prevent pathological brain aging.
Key words: aging; endoplasmic reticulum; endoplasmic
reticulum stress; protein misfolding disorders; unfolded
protein response.
Introduction
As the world population gets older, dementia emerges as a major public
health issue worldwide, particularly in middle- and middle-to-high-
income countries. The prevalence of dementia increases exponentially
with age, affecting 5–10% of people over 65, and about 50% of people
over 85. In 2011, dementia was estimated to affect 35.6 million people
around the world, and it is expected to reach about 135 million by 2050
(Brayne, 2007; World Health Organization and Alzheimer’s Disease
International 2012). Reduced cognitive function is a common trait
present in elderly individuals, which correlates with substantial alter-
ations to functional synapses and normal neuronal physiology at the
cellular and molecular level (Leal & Yassa, 2015). Accordingly, a
significant percentage of aged individuals will manifest some sort of
dementia in the form of a collection of neurodegenerative diseases,
transposing the line between normal aging (healthspan) to pathological
brain aging (Brayne, 2007). Recently, several interconnected processes
have been defined as the hallmarks of aging, where substantial
alterations to cellular proteostasis is proposed as one of the major pillars
of aging (Lopez-Otin et al., 2013; Kennedy et al., 2014).
The proteostasis network is decomposed into different subpathways
highly conserved across evolution and comprehends a collection of
mechanisms related to protein synthesis, folding, trafficking, secretion,
and degradation distributed in different compartments inside the cell
(Balch et al., 2008; Powers & Balch, 2013). The main players of this
network include chaperones and foldases, the ubiquitin–proteasome
system, the autophagy pathway, the heat-shock response, the unfolded
protein response (UPR), the integrated stress response, the endoplasmic
reticulum (ER)-associated degradation machinery (ERAD), the mitochon-
drial UPR, and the mechanisms controlling redox balance (Balch et al.,
2008). Those processes are dynamic and tightly coordinated by quality
control systems to avoid proteotoxicity and ensure that unfolded or
misfolded proteins do not accumulate into cytotoxic aggregates (Labba-
dia & Morimoto, 2014). Various pathological conditions affecting the
nervous system share common molecular features despite presenting
different clinical manifestations, highlighting the presence of abnormal
protein aggregates in the brain of affected individuals (Walker et al.,
2015). These age-related diseases are classified as protein misfolding
disorders (PMDs) and include Alzheimer’s disease (AD), Parkinson’s
disease (PD), amyotrophic lateral sclerosis (ALS), Huntington’s disease
(HD), prion-related disorders (PrDs), among others (Soto, 2003). Impor-
tantly, one of the main nodes of the proteostasis network involved in
aging and PMDs is the UPR and the occurrence of abnormal levels of ER
stress. Recent advances in model organisms have uncover the significance
of the UPR to the control of global proteostasis during aging, where the
nervous system has a central role in monitoring alterations in the health of
the proteome to adjust the capacity of the cell to cope with ER stress in
various peripheral tissues. Here, we discuss new concepts illustrating the
functional relevance of the UPR to organismal aging across species and its
significance as a risk factor to develop neurodegenerative diseases.
The unfolded protein response
The ER is the main site for the synthesis and folding of around one-third
of the total proteome of a cell (Braakman & Bulleid, 2011). Considered a
key component of the proteostasis network, ER-located proteins
regulate folding and quality control through the activity of multiple
chaperones, foldases, and co-factors that assist the folding of nascent
proteins as well as degradation pathways, thus preventing abnormal
protein aggregation and resultant proteotoxicity (Ellgaard & Helenius,
2003; Kourtis & Tavernarakis, 2011; Hetz et al., 2015). Stressful stimuli
such as hypoxia (Badiola et al., 2011), nutrient deprivation (Szegezdi
et al., 2006), increased protein oxidation (Santos et al., 2009), and
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disturbance of the secretory pathway (Badr et al., 2007) may lead to an
excessive accumulation of misfolded proteins at the ER, a process termed
ER stress (Walter & Ron, 2011; Hetz, 2012). To cope with ER stress, a
highly conserved signaling pathway is engaged known as the UPR (Wang
& Kaufman, 2016). The UPR is initiated by the activation of at least three
types of stress sensors including inositol-requiring enzyme-1 (IRE1), PKR-
like ER kinase (PERK), and activating transcription factor 6 (ATF6). IRE1
catalyzes the unconventional splicing of the mRNA encoding X-box
binding protein-1 (XBP1) (Yoshida et al., 2001; Calfon et al., 2002; Lee
et al., 2002), resulting in the expression of an active transcription factor
called XBP1s that controls the expression of a cluster of genes related to
folding and quality control mechanisms (Hetz et al., 2011). Additionally,
IRE1 also degrades several mRNAs, ribosomal RNAs, and microRNAs
through a process known as regulated IRE1-dependent decay (RIDD),
having an impact on different processes including inflammation and
apoptosis (Maurel et al., 2014). IRE1 also engages distinct stress
pathways, including JNK and NF-jB, through the binding of adapter
proteins (Hetz et al., 2015). Activation of PERK leads to the phospho-
rylation of the eukaryotic translation initiation factor 2 alpha (eIF2a),
which in turn inhibits translation decreasing protein influx into the ER
(Ron & Walter, 2007). Paradoxically, some mRNAs, including activating
transcription factor 4 (ATF4), are differentially translated, leading to the
upregulation of genes related to redox homeostasis, amino acid
metabolism, autophagy, and apoptosis control (Harding et al., 2003;
Ye & Koumenis, 2009; B’Chir et al., 2014). Moreover, PERK activation
has been shown to modulate the activity of nuclear factor erythroid 2-
related factor 2 (NRF2) and forkhead box O (FOXO), linking this pathway
to the antioxidant response, insulin responsiveness, and autophagy
(Chevet et al., 2015). Under ER stress conditions, ATF6 translocates to
the Golgi apparatus where it is cleaved releasing ATF6f, a cytosolic active
form. ATF6f exerts its action at the nuclear level as a transcription factor
regulating genes associated with ERAD, in addition to enhancing XBP1
mRNA transcription (Yamamoto et al., 2007). Importantly, the control of
gene expression by the UPR depends on the cellular context and the
stimuli considering that UPR transcription factors can interact with other
proteins to drive specific responses, in addition to be regulated by several
post-translational modifications (Hetz et al., 2015). Under chronic ER
stress, the UPR triggers apoptosis through different mechanisms that
involve the upregulation of CHOP, the induction of oxidative stress,
exacerbated RIDD, upregulation of pro-apoptotic components of the
BCL-2 family, among other mechanisms (Tabas & Ron, 2011; Urra et al.,
2013). Thus, under conditions of ER stress, the UPR reprograms the cell
toward adaptation, sustaining cell function or the engagement of cell
death programs to eliminate irreversibly damaged cells.
ER proteostasis and aging in simple model
organisms
During aging, organisms gradually accumulate intracellular aggregates
composed by misfolded proteins, an event that is associated with a
prominent decline in the buffering capacity of the proteostasis network
and a consequent decrease in tissue and cellular function (Fig. 1) (Taylor
& Dillin, 2011; Triplett et al., 2015). Several studies in model organisms
have uncovered the significance of UPR signaling to the aging process,
associated with protection against proteotoxicity (Ben-Zvi et al., 2009;
Labunskyy et al., 2014). For example, caloric restriction has been used as
a major strategy to prevent the adverse effects of aging on healthspan
(Riera & Dillin, 2015). In yeast, this intervention correlates with increased
expression of HAC1, the functional homologue of XBP1s (Choi et al.,
2013). Remarkably, genetic ablation of HAC1 abrogates the lifespan
extension conferred by caloric restriction (Choi et al., 2013). Other
studies indicated that the deletion of distinct UPR-target genes impact
replicative lifespan in yeast, a process dependent on the Ire1p/HAC1 axis
(Labunskyy et al., 2014). Furthermore, genetic modifications to improve
the activity of the UPR enhance replicative lifespan in Saccharomyces
cerevisiae (Cui et al., 2015).
Studies in Caenorhabditis elegans have revealed a fundamental role
of the UPR in adjusting organismal proteostasis during aging through a
neuronal control. Exposure of Caenorhabditis elegans to pharmacolog-
ical inducers of ER stress indicated that the ability of aged worms to
respond is significantly reduced compared with young animals (Ben-Zvi
et al., 2009). Interestingly, the same observation was reported when
animals were stimulated with heat shock (Ben-Zvi et al., 2009),
suggesting global proteostatic defects during aging. Enforced expression
of heat-shock factor 1 (HSF-1) or the FOXO-transcription factor DAF-16
restores proteostasis of aged worms (Ben-Zvi et al., 2009). Loss-of-
function studies in Caenorhabditis elegans demonstrated that lifespan
extension conferred by XBP1 expression is dependent on insulin/IGF-1-
FOXO signaling, a classical pathway associated with aging (Henis-
Korenblit et al., 2010; Douglas et al., 2015). Importantly, lifespan
extension was only achieved through the parallel interaction between
XBP1 and FOXO-transcription factor DAF-16, which acts in conjunction
to genes related to longevity (Henis-Korenblit et al., 2010). According to
these observations, Taylor and Dillin demonstrated that the selective
overexpression of Xbp1s in neurons or intestine strongly reverts the age-
related susceptibly to ER stress stimulation (Table 1) (Taylor & Dillin,
2013). Remarkably, the overexpression of XBP1s in neurons has a strong
impact on lifespan extension, augmenting animal survival up to 30%. A
recent study also indicated that loss-of-function mutations in distinct
subunits of translation initiation factor eIF-3 confer a 40% extension in
the lifespan of Caenorhabditis elegans through a DAF-16-dependent and
UPR-independent pathway (Cattie et al., 2016), suggesting that differ-
ent nodes of the proteostasis network significantly contribute to aging in
worms.
Studies in flies have also defined contributed to define the relevance
of the UPR to the aging process. Intestinal stem cells in Drosophila
melanogaster promote a regenerative response upon UPR activation, a
process deregulated during aging (Wang et al., 2014). Later, Wang
et al. demonstrated that PERK is specifically activated in intestinal stem
cells, having a functional role in promoting healthspan in flies. However,
chronic engagement of this pathway becomes deleterious during aging
in Drosophila melanogaster (Wang et al., 2015). A previous study also
indicated that Xbp1 is both sufficient and required to limit intestinal stem
cell proliferation (Wang et al., 2014). Recently, the same group reported
that engagement of the Ire1/Xbp1 branch also results in lifespan
extension in the same model under dietary restriction. The activation of
Ire1/Xbp1 pathway in enterocytes under dietary restriction has a positive
impact on lifespan of gut cells by regulating lipid synthesis (Luis et al.,
2016). Overall, the functional significance of ER stress signaling to
lifespan control has been inferred from several studies in simple model
organisms.
Cell-nonautonomous control of organismal aging
by the UPR
A novel concept is emerging based on research using fly and worm
models of aging, indicating that the ER proteostasis network promotes
health and lifespan through cell-nonautonomous mechanisms, impact-
ing whole organismal proteostasis (Mardones et al., 2015). Studies in
Caenorhabditis elegans revealed that besides its importance in individual
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cells, the UPR acts as a key player in modulating global organism
adaptability to stress during aging by integrating information at the level
of the nervous system (Martinez et al., 2016a). Accordingly, UPR can be
activated on a cell-nonautonomous manner (Taylor & Dillin, 2013). The
ectopic expression of XBP1s in neurons is able to engage a distal UPR
activation in the intestine, thus increasing stress resistance and longevity
in Caenorhabditis elegans (Taylor & Dillin, 2013). These results suggest
that the nervous system may act as a central integrator and adjustor of
global proteostasis, with possible major distal effects in the intestine.
Importantly, other studies previously demonstrated that neuronal UPR
regulates the innate immunity in the gut on a cell-nonautonomous
manner (Martinez & Hetz, 2012; Sun et al., 2012; Aballay, 2013).
Chromatin remodeling factors in neurons can also engage ER stress
responses through a cell-nonautonomous mechanism (Kozlowski et al.,
2014). Thus, accumulating evidence supports the idea that when an
organism is exposed to environmental or pathogenic challenges, the
ability of the nervous system to integrate these signals through the
activation of the UPR favors the maintenance of homeostasis in various
peripheral organs (Mardones et al., 2015). A similar model has been
proposed for the heat-shock response by Morimoto’s group, where HSF-
1 in neurons regulates global responses to aging in the gut (Morley &
Morimoto, 2004; van Oosten-Hawle & Morimoto, 2014a; Douglas et al.,
2015). Importantly, cell-nonautonomous control of aging-related path-
ways has been extensively described in different model organisms
mediated by distinct signaling molecular mediators (Taylor et al., 2014;
Leiser et al., 2015; Schinzel & Dillin, 2015). A recent study indicated that
PERK is activated in intestinal stem cells by JAK/Stat signaling in response
to ER stress in neighboring cells, regulating intestinal homeostasis and
lifespan in flies (Wang et al., 2015). A cell-nonautonomous mechanism
has been also described in mammals, where overexpression of XBP1s in
the hypothalamus modulates global energy balance through the
propagation of signals to the liver and adipose tissue to adjust energy
metabolism (Williams et al., 2014). Furthermore, the concept of
‘transcellular chaperone signaling’ was proposed in Caenorhabditis
Fig. 1 The buffering capacity of the
proteostasis network decreases with aging.
The aging process is directly associated with
a range of specific alterations in distinct
components of the proteostasis network.
Such alterations disrupt the healthy
functioning of cell and may contribute to
the emergence of disease.
Table 1 Genetic manipulation of the unfolded protein response (UPR) affecting the aging process in different model organisms. Examples of genetic manipulation to UPR
components in different species that modifies lifespan with modified genetic backgrounds (Alg12, Bst1, Pmt-1, or Daf-2 mutants) or under metabolic stimulus (caloric or
dietary restriction)
Model organism/species Genetic modification of UPR Effect on aging Stimulus/genetic background References
Saccharomyces cerevisiae Decreased expression of Hac1 Decreased lifespan Caloric restriction Choi et al. (2013)
Deletion of Hac1 or Ire1p Decreased lifespan Deletion of Alg12 and Bst1 Labunsky et al. (2014)
Deletion of Hac1 or Ire1p Decreased replicative lifespan Deletion of Pmt-1 Cui et al. (2015)
Caenorhabditis elegans Deletion of Ire1 or Xbp1 Decreased lifespan Deletion of Daf-2 Henis-Korenblit et al. (2010)
Deletion of Atf6 No effect on lifespan Deletion of Daf-2
Overexpression of Xbp1 and Daf-16 Extended lifespan, through
the expression of longevity genes
Deletion of Daf-2
Neuronal overexpression of Xbp1s Increased lifespan through
cell-nonautonomous mechanism
Basal levels Taylor & Dillin (2013)
Drosophila melanogaster Deletion of Perk on intestinal stem cells Increased lifespan Basal levels Wang et al. (2015)
Deletion of Ire1 or Xbp1 Decreased lifespan Dietary restriction Luis et al. (2016)
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elegans where cells suffering stress from the accumulation of protein
aggregates propagate signals to the neighbor tissue to induce adaptive
responses and resist further damage (van Oosten-Hawle & Morimoto,
2014b).
The molecular components that enable communication or signal
propagation from neurons to the periphery are still unknown. It also
remains to be established whether the activation of the UPR through
cell-nonautonomous mechanisms depends on the induction of ER stress
in the target tissue or whether it is actually mediated by signaling events
that engage UPR sensors in the absence of stress features (Mardones
et al., 2015). This second possibility may be feasible since many
examples are available showing that UPR stress sensors can be
modulated by post-translational modifications or protein–protein inter-
actions in the absence of protein misfolding (Hetz, Chevet et al., 2015).
Taylor and Dillin showed that the induction of cell-nonautonomous UPR
responses depends on the release of small clear vesicles from synaptic
terminals of neurons expressing XBP1s (Taylor & Dillin, 2013). Addition-
ally, XBP1s expression in neurons can promote the expression of brain-
derived neurotrophic factor (BDNF), which may in turn engage IRE1
signaling in a stress-independent manner (Martinez et al., 2016b). Still,
the specific mechanism of global proteostasis control in mammals and
the neuronal circuits governing the propagation of UPR signals between
cells remain to be determined. Although cell-nonautonomous control of
proteostasis has been validated in simple model organisms during aging,
the occurrence of this process in mammals is still an open question.
Overall, these examples illustrate how stress signals spread systemically
in the organism to induce adaptive programs.
ER stress response in mammalian aging
Although proteostasis impairment and ER stress are proposed as one of
the hallmarks of aging, most of the studies addressing the contribution
of the UPR to mammalian aging rely mostly on correlative data. For
example, the expression of the ER chaperones BiP, calnexin, and PDI has
been reported to be downregulated in the hippocampus of aged rats
while pro-apoptotic mediators such as CHOP and the ER-located
caspase-12 are increased (Paz Gavilan et al., 2006; Gavilan et al.,
2009). Additionally, another report demonstrated that levels of both
ATF4 and BiP are decreased in this tissue (Hussain & Ramaiah, 2007). In
aged brains, basal expression of PERK, GADD34, and total eIF2a is
augmented contrasting with reduced levels of eIF2a phosphorylation
(Hussain & Ramaiah, 2007). Moreover, young mice under sleep
deprivation showed an increase in BiP and eIF2a phosphorylation, which
was not observed in aged mice, but there was an upregulation of
GADD34, CHOP, and caspase-12 (Naidoo et al., 2008). Another study
demonstrated similar observations in the pancreas of mice (Naidoo et al.,
2014). Additionally, aged macrophages exhibit diminished IRE1 activa-
tion and increased susceptibility to ER stress-dependent apoptosis (Song
et al., 2013). These findings suggest that the ability to engage the UPR
may be disrupted during aging; however, the functional significance of
these observations is unknown (Fig. 2).
In contrast, several reports suggest that chronic ER stress is associated
with aging in multiple tissues. Increased levels of CHOP, ATF4, and
XBP1s were observed in primary osteocytes from aged mice when
compared to adult mice exposed to ER stress-inducing agents (Chalil
et al., 2015). Similar results were reported in stromal cells from adipose
tissue of aged mice, associated with augmented levels of BIP, CHOP,
ATF6, and phosphorylated IRE1 (Ghosh et al., 2015). CHOP was also
shown to be induced at baseline in muscular tissue of the hindlimb of
aged rats (Baehr et al., 2016). Of interest, gene expression profile studies
demonstrated that UPR-target genes are one of the most affected
pathways in bone marrow during aging (Kannan et al., 2016). At the
level of the central nervous system, phosphorylation of CHOP, ATF6,
GADD34, ATF4, and eIF2a are also upregulated in the retina of aged rats
(Lenox et al., 2015).
ER stress signaling components have been shown to interact with
classical aging-related pathways suggesting a functional interconnec-
tion. For example, in the context of HD, we showed that XBP1 negatively
regulates FOXO1 levels (Vidal et al., 2012). Several reports have also
linked ER stress responses with the control of autophagy (reviewed in
Vidal et al., 2014), a central pathway involved in proteostasis control
(Kaushik & Cuervo, 2015). Insulin signaling is also linked to IRE1
function, as demonstrated in models of diabetes and obesity (Ozcan
et al., 2004). Overall, these studies depict a general concept where
mammalian aging is directly associated with the occurrence of chronic
ER stress. Those findings may be explained by accumulative ER damage
rather than an attenuation of UPR responses. Currently, functional
analysis is needed to define the actual contribution of ER proteostasis to
mammalian aging. Since a variety of mouse models are available to
target specific UPR components in various tissues (Cornejo et al., 2013),
the means to answer this fundamental question are already available.
Aging as a risk factor to undergo
neurodegeneration: a role of ER stress?
Abnormal aggregation of specific proteins is a hallmark of age-related
neurodegenerative diseases. Increasing evidence indicates that despite
the fact that PMD-related proteins distribute in different subcellular
locations and have distinct binding partners, a common pathological
consequence of their accumulation is the occurrence of ER stress. This
mechanistic convergence is explained by the observation that disease-
related proteins actually disrupt the function of one or more components
of the proteostasis network, highlighting the inhibition of ERAD, altered
vesicle trafficking between the ER and Golgi, perturbed ER calcium
homeostasis, autophagy dysregulation, and abnormal interactions with
ER chaperones (Hetz & Mollereau, 2014; Vidal et al., 2014; Kaushik &
Cuervo, 2015).
Importantly, with the exception of HD, familiar cases of PMDs
account for less than 10% of cases, indicating that protein aggregation
occurs in the absence of genetic mutations to the affected proteins. This
observation suggests that alteration in different components of the
proteostasis network during aging may contribute to protein aggrega-
tion. The involvement of ER stress in PMDs is highly complex, acting both
as protective or detrimental (Hetz & Mollereau, 2014; Scheper &
Hoozemans, 2015; Freeman & Mallucci, 2016). Indeed, the activity of
the UPR in neurodegenerative diseases could either enhance or reduce
neurodegeneration, depending on the process that is modulated by
specific ER stress signals and the particular disease studied. A strong
correlation between ER stress markers and signs of neurodegeneration
has been reported in human postmortem tissue and animal models of
PMDs. Remarkably, human neurons derived from induced pluripotent
stem cells of AD, PD, and ALS patients revealed that ER stress is a
prominent feature of this disease model (Chung et al., 2013; Kondo
et al., 2013; Matus et al., 2014; Lee & Huang, 2017). Other studies also
suggest that ATF4 may enhance axonal degeneration in AD through cell-
nonautonomous mechanisms (Baleriola et al., 2014; Wei et al., 2015).
Importantly, the repressive effects of ER stress over protein synthesis
were shown to contribute to the cognitive impairment observed in AD
and PrD models by blocking the expression of synaptic proteins (Moreno
et al., 2012, 2013; Freeman & Mallucci, 2016). Studies in
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Drosophila melanogaster (Loewen & Feany, 2010; Casas-Tinto et al.,
2011) and Caenorhabditis elegans (Safra et al., 2013) reported a
functional role of XBP1 in neurodegeneration in AD. Interestingly, a
polymorphism in the XBP1 promoter previously associated with bipolar
disorders and schizophrenia (Kakiuchi et al., 2003; Du et al., 2008; Kim
et al., 2009) was also pointed as a risk factor to develop AD in the
Chinese population (Liu et al., 2013). In agreement with these findings,
a new physiological function of XBP1 was proposed in the hippocampus
in the control of learning and memory processes (Martinez et al.,
2016b).
Genetic ablation of XBP1 in the nervous system uncovered a dynamic
interconnection between the UPR and the autophagy pathway to handle
protein aggregation. XBP1 deficiency protects against the development
of experimental HD and ALS due to an increase in autophagy levels (Hetz
et al., 2009; Vidal et al., 2012). In the context of PD, XBP1 deficiency
also provided neuroprotection associated with the basal upregulation of
several components of the ER proteostasis network, possibly reflecting
the induction of nonlethal stress levels at the substantia nigra (Valdes
et al., 2014). The concept of hormesis was proposed as an adaptive
mechanism where a mild perturbation to neuronal proteostasis triggers
compensatory mechanisms that enhance the capacity of the cell to cope
with stress (Mollereau et al., 2016). In fact, treatment of animals with
nonlethal doses of the ER stress agent tunicamycin (an inhibitor of
N-glycosylation) provides protection against PD possibly due to the
induction of autophagy (Fouillet et al., 2012). Many other functional
studies illustrate the therapeutic consequences of enforcing UPR
adaptive outputs in ALS, PD, and HD (reviewed in Hetz & Mollereau,
2014; Freeman & Mallucci, 2016; Scheper & Hoozemans, 2015).
Recent evidence suggests that ER stress may underlay the differential
neuronal vulnerability observed in neurodegenerative diseases, where
most of the advances have been reported in ALS models (Rozas et al.,
2016; Ruegsegger & Saxena, 2016). Disruption to the ER folding
network is emerging as a key factor underlying the susceptibility of
specific neuronal populations to undergo neurodegeneration (Filezac de
L’Etang et al., 2015). In addition, genetic evidence has placed the ER
proteostasis network in the etiology of ALS as mutations in two-disulfide
isomerase (PDIA1 and ERp57) were proposed as risk factors to develop
ALS (Gonzalez-Perez et al., 2015; Woehlbier et al., 2016). Alterations to
the ER folding network may result in abnormal synthesis of synaptic
proteins, having a negative effect on the integrity of neuromuscular
junctions and neuronal connectivity (Bernard-Marissal et al., 2012,
2015; Woehlbier et al., 2016). Similarly, genetic inactivation in BiP or
its cofactor SIL1 results in spontaneous degeneration, leading to
abnormal protein aggregation during aging (Zhao et al., 2005; Jin
Fig. 2 Endoplasmic reticulum (ER) stress in
aging across species. The aging process is
directly associated with a range of specific
alterations in distinct components of the ER
proteostasis network in different tissues,
highlighting changes in components of the
unfolded protein response and the folding
machinery.
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et al., 2014). Taken together, these studies suggest that alterations to
the function of the ER during aging may contribute to synaptic
dysfunction and abnormal protein aggregation, increasing the risk to
develop neurodegenerative diseases.
Concluding remarks
Imbalance of neuronal proteostasis is one of the pathological hallmarks
of aging, and understanding its molecular defects will contribute to
develop strategies to intervene age-associated disorders. Because the
nervous system is highly dynamic and plastic, the manifestation of
clinical features in patients arises very late, after severe damage has
already occurred. Likely, it is predicted that the development of
strategies to improve the quality of the aging process will substantially
reduce the probability to undergo PMDs. Despite the fact that
proteostasis is composed of a complex network of individual intercon-
nected signaling pathways, recent findings suggest that the mainte-
nance of ER physiology is a prominent molecular target to prevent age-
related diseases affecting the nervous system. The involvement of ER
stress in the biology of aging is complex as illustrated by most recent
advances. The activity of the ER proteostasis network may not only
operate as a mechanism to handle abnormal protein aggregation, but it
is also proposed as an adjuster of brain function through fine-tuning
synaptic function. Specific neuronal populations are highly vulnerable to
perturbations to ER function possibly because their metabolic state
depends on the basal activity of the UPR. Furthermore, the UPR may
orchestrate repair processes of the nervous system by controlling the
expression of neurotrophins such as BDNF, and the regenerative capacity
of axons and stem cells pools (Castillo et al., 2015; Martinez et al.,
2016b; Onate et al., 2016). Regarding inflammatory reactions, the UPR
is known to have important functions in macrophages and dendritic cells
by modulating the secretion of pro-inflammatory cytokines (Bettigole &
Glimcher, 2015). In this context, future efforts should address the
importance of the UPR to brain inflammation and the activity of
astrocytes, microglia, and oligodendrocytes during aging. The fact that
the UPR participates in the adjustment of energy and lipid metabolism,
an additional layer of complexity, could be also explored to link the UPR
with brain aging. Finally, the discovery of cell-nonautonomous UPR
responses and its relation to healthspan control adds a new concept as
ER stress-related signals in the brain may influence the capacity of the
whole organism to adapt and cope with ER stress. All those aspects
should be considered in future studies aiming to define the relative
impact of ER stress on mammalian brain aging and its significance as a
risk factor to develop neurodegenerative diseases.
Several novel small molecules are available to target selective UPR
components and reduce ER stress levels (Table 2; Hetz et al., 2013; Maly
& Papa, 2014; Gallagher & Walter, 2016; Gallagher et al., 2016; Axten,
2017), which promises possible new avenues to intervene the aging
process. Importantly, some of these compounds have already been
tested in preclinical models of PMDs (Table 2). However, it is important
to consider possible side effects as the activity of the UPR has been linked
to the physiology of many peripheral organs and the long-term
administration of UPR-targeting drugs is predicted to induce liver failure,
altered immune system function, pancreatic problems, among others
maladies (Dufey et al., 2014). In this scenario, gene therapy is emerging
as a strategy to locally reduce ER stress by delivering adaptive
components of the UPR (i.e., XBP1s, BiP) specifically into the brain
regions affected by distinct neurodegenerative diseases (Valenzuela
et al., 2016). Overall, although the UPR is emerging as a central and
evolutionarily conserved modulator of the normal process of aging, data
available in mammalian systems are still correlative and remain to be
functionally explored. As the UPR field has greatly evolved in the last five
years in terms of generation of animal models and pharmacological
tools, it is expected to witness future advances to underscore the
significance of the UPR to brain aging and its relation to neurodegen-
erative diseases.
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